Lifeboat Foundation

Senior director, milken institute center for the future of aging, milken institute; executive director, alliance to improve dementia care.

Nora Super is the Senior Director of the Milken Institute Center for the Future of Aging (CFA) (https://milkeninstitute.org/centers/center-for-the-future-of-aging) and the Executive Director of the Milken Institute Alliance to Improve Dementia Care (https://milkeninstitute.org/centers/center-for-the-future-of…tia-care).

Continue reading “Nora Super — Milken Institute — Center for the Future of Aging — Alliance to Improve Dementia Care” »

2 sticks of RAM giving you 1TB of memory will be the norm soon.

While consumers today typically use computers with 8GB or 16GB of DDR4 RAM inside, Samsung is pushing ahead with the next generation of memory modules. Its latest stick of RAM is a 512GB DDR5 module running at 7200Mbps.

The new module will be used in servers performing “the most extreme compute-hungry, high-bandwidth workloads.” That means supercomputers, artificial intelligence, and machine learning. It was made possible thanks to advanced HKMG technology, which Samsung adopted back in 2018 for its GDDR6 memory. Basically, HKMG replaces the insulator layer in DRAM structures. The high dielectric material contained in the layer reduces current leakage and therefore allows higher performance. At the same time, Samsung managed to reduce power usage in the new module by 13%.

Continue reading “Samsung Develops a Very Fast 512GB DDR5 Memory Module” »

Elon Musk has made the argument that Tesla is more of an AI (artificial intelligence) and robotics company. This is another argument in the series of Musk’s insistence that Tesla is not an automotive company. He has been saying for some time now that investors should view Tesla as a group of startups. He says that Tesla’s service centres are a startup, Tesla’s insurance company is a startup, Tesla’s automation group is a startup, etc.

Musk said that eventually, Tesla is going to be as synonymous with AI and robotics as with vehicles and energy. The CEO mentioned this during a conference call about Tesla’s Q1 financial results.

Right now people think of Tesla as a car company or as an energy company. I think long term, people will think of Tesla as much as an AI robotics company as we are a car company or an energy company. I think we are developing one of the strongest hardware and software AI teams in the world.

Cryptocurrencies like Bitcoin have been billed as a major disruptor to finance. But digital currencies issued by governments might be even more radical—they may even threaten the future of traditional banking.

Read our special report, “The Future of Banking” : https://econ.st/3tuTT8y.

Continue reading “Could digital currencies put banks out of business? | The Economist” »

Deep-tech healthcare & energy investments for a sustainable future — dr. anil achyuta, investment director / founding member, TDK ventures.

Dr. Anil Achyuta is an Investment Director and a Founding Member at TDK Ventures, which is a deep-tech corporate venture fund of TDK Corporation, the Japanese multinational electronics company that manufactures electronic materials, electronic components, and recording and data-storage media.

Continue reading “Dr. Anil Achyuta — TDK Ventures — Founding Member — Deep-Tech Healthcare And Energy Investments” »

Cryptocurrency can help Africans access the global financial system, writes Akon, artist and founder of Akoin.

Saudi Arabia could save some $200 billion over the next ten years by switching from crude oil to natural gas and renewables for electricity production, Reuters reports, citing the Kingdom’s Finance Minister.

“Instead of buying fuel from the international markets at $60 and then selling it at $6 for Saudi utilities, or using some of our quota in OPEC to sell at $6, we’re going to actually displace at least 1 million barrels a day of oil equivalent in the next 10 years and replace it with gas and renewables,” Mohammed al-Jadaan said.

OPEC’s largest oil producer and world’s largest exporter of crude is on a desperate quest to reduce its dependence on oil revenues by diversifying its economy away from the flagship export stock. Earlier this year, Crown Prince Mohammed, who appears to be the de facto ruler of Saudi Arabia, announced yet another investment program with a view to this diversification that he said would “unlock new local investments valued at SAR 5 Trillion through the end of 2030.”

In this nearly 4-hour SPECIAL EPISODE, Rob Reid delivers a 100-minute monologue (broken up into 4 segments, and interleaved with discussions with Sam) about the looming danger of a man-made pandemic, caused by an artificially-modified pathogen. The risk of this occurring is far higher and nearer-term than almost anyone realizes.

Rob explains the science and motivations that could produce such a catastrophe and explores the steps that society must start taking today to prevent it. These measures are concrete, affordable, and scientifically fascinating—and almost all of them are applicable to future, natural pandemics as well. So if we take most of them, the odds of a future Covid-like outbreak would plummet—a priceless collateral benefit.

Rob Reid is a podcaster, author, and tech investor, and was a long-time tech entrepreneur. His After On podcast features conversations with world-class thinkers, founders, and scientists on topics including synthetic biology, super-AI risk, Fermi’s paradox, robotics, archaeology, and lone-wolf terrorism. Science fiction novels that Rob has written for Random House include The New York Times bestseller Year Zero, and the AI thriller After On. As an investor, Rob is Managing Director at Resilience Reserve, a multi-phase venture capital fund. He co-founded Resilience with Chris Anderson, who runs the TED Conference and has a long track record as both an entrepreneur and an investor. In his own entrepreneurial career, Rob founded and ran Listen.com, the company that created the Rhapsody music service. Earlier, Rob studied Arabic and geopolitics at both undergraduate and graduate levels at Stanford, and was a Fulbright Fellow in Cairo. You can find him at www.after-on.

Rejuvenate Bio’s treatment is a gene therapy that dials up expression of the genes sTGFbetaR2 and FGF21 to reduce levels of the cytokine TGF-beta1 and boost levels of the hormone FGF21, respectively. Both genes are associated with longevity.

“What we have seen from using a combination of two genes is the ability to affect multiple age-related diseases at once,” Oliver said.

Rejuvenate Bio published data in November 2019 showing that targeting these two genes in mice reduced kidney atrophy and reversed weight gain and Type 2 diabetes. The company had given extra copies of those genes, alone and in combination with each other and another gene called alpha-Klotho to see if they could boost the mice’s health and life spans. It found out that more isn’t necessarily better, as mice that were given all three genes together fared worse than the other animals did.